Rutgers University Hospital

Newark, New Jersey 07103

2 studies enrolling now · 11 studies all time

What they study most

Acute Alcoholic Hepatitis, Acute Liver Failure, COVID-19, COVID-19 Pulmonary Complications, Covid19, Diabetes Mellitus, Fulminant Hepatic Failure, Hepatic Encephalopathy, Hyperbilirubinemia, Neonatal, Jaundice, Neonatal, Liver Cancer, Liver Cirrhosis

Studies at this site

• High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED) — Recruiting now
• Endoscopic Shunts Embolization for Refractory Hepatic Encephalopathy — Starting soon
• Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants — Completed
• The Impact of Diabetes on REvascularization — Completed
• Measurement of Viral Load Reduction in the Oral Cavity After a Regimental Use of OC Toothpaste Products — Completed
• Beraprost-314d Added-on to Tyvaso® (BEAT) — Completed
• Stannsoporfin With Light Therapy for Newborn Babies With Jaundice — Completed
• To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure — Stopped early
• Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF) — Stopped early
• Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD — Stopped early
• Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery — Completed